Trial Profile
Clinical study for apatinib combined with Stupp regimen in the treatment of Recurrent high-grade glioma
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2020
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Temozolomide (Primary) ; Alkylating agents
- Indications Glioma
- Focus Therapeutic Use
- 26 Oct 2018 New trial record